Can Atalay
Impact in
-
- Breast Cancer Treatment Studies
-
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
Papers in
- Co-authors
- Kerim Bora Yılmaz (15 shared papers)Ufuk Gündüz (4 shared papers)Lütfi Doğan (17 shared papers)Cihangir Özaslan (17 shared papers)Çiğdem Irkkan (4 shared papers)Meltem Demirel Kars (1 shared paper)Özlem Darcansoy İşeri (1 shared paper)Fikret Arpacı (1 shared paper)
- Journals
- Surgery Today (4 papers)World Journal of Clinical Oncology (1 paper)Experimental Lung Research (1 paper)Japanese Journal of Clinical Oncology (1 paper)Biomedicine & Pharmacotherapy (1 paper)
- Partner nations
- TürkiyeVietnamUnited States
In The Last Decade
Can Atalay
54 papers receiving 631 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 128
- Oncology 197
- Pathology and Forensic Medicine 73
- Surgery 127
- Dermatology 23
Countries citing papers authored by Can Atalay
This map shows the geographic impact of Can Atalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Atalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Atalay more than expected).
Fields of papers citing papers by Can Atalay
This network shows the impact of papers produced by Can Atalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Atalay. The network helps show where Can Atalay may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Atalay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 102 | |
| 2 | 2009 | 35 | |
| 3 | 2008 | 33 | |
| 4 | 2003 | 32 | |
| 5 | 2006 | 26 | |
| 6 | 2012 | 25 | |
| 7 | The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. | 2005 | 25 |
| 8 | 2011 | 21 | |
| 9 | 2010 | 20 | |
| 10 | 2005 | 20 | |
| 11 | 2008 | 19 | |
| 12 | Prognostic factors affecting survival in male breast cancer. | 2003 | 19 |
| 13 | Epigenetics in breast cancer. | 2013 | 18 |
| 14 | 2005 | 16 | |
| 15 | 2009 | 16 | |
| 16 | 2014 | 15 | |
| 17 | Menstrual cycle and hormone receptor status in breast cancer patients. | 2002 | 13 |
| 18 | 2013 | 12 | |
| 19 | Characteristics and risk factors for colorectal cancer recurrence. | 2010 | 12 |
| 20 | 2013 | 10 |
About Can Atalay
Can Atalay is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 57 papers that have together received 662 indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (8 papers), Breast Cancer Treatment Studies (7 papers), Drug Transport and Resistance Mechanisms (5 papers), Cancer and Skin Lesions (4 papers), Estrogen and related hormone effects (3 papers), Reconstructive Surgery and Microvascular Techniques (3 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer Risks and Factors (3 papers). The work is most often cited by research in Cancer Research (128 citations), Oncology (197 citations), Pathology and Forensic Medicine (73 citations), Surgery (127 citations) and Dermatology (23 citations). Can Atalay has collaborated with scholars based in Türkiye, Vietnam and United States. Frequent co-authors include Kerim Bora Yılmaz, Ufuk Gündüz, Lütfi Doğan, Cihangir Özaslan, Çiğdem Irkkan, Meltem Demirel Kars, Özlem Darcansoy İşeri, Fikret Arpacı, Bahadır Çetin and Melih Akıncı. Their work appears in journals such as Surgery Today, World Journal of Clinical Oncology, Experimental Lung Research, Japanese Journal of Clinical Oncology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.